Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,067,358
+$3,168,334 QoQ
Shares Held
374,251
+41.3% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 625 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORGES BANK holds $48,449,655,630 across 13 Drug Manufacturers - General names. OGN ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,471,413 | $13,759,158,041 | |
| 2 | JNJ |
Johnson & Johnson
|
31,825,084 | $8,082,616,583 | |
| 3 | ABBV |
AbbVie Inc.
|
25,554,538 | $6,430,543,942 | |
| 4 | AZN |
Astrazeneca PLC
|
33,864,172 | $6,421,324,294 | |
| 5 | MRK |
Merck & Co., Inc.
|
36,983,784 | $4,752,416,244 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,965,555 | $2,775,128,218 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,866,658 | $2,124,256,833 | |
| 8 | AMGN |
Amgen Inc
|
5,625,584 | $2,037,136,478 |
All Filings in OGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,067,358 | 374,251 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $1,899,024 | 264,857 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $19,777,721 | 2,043,153 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $14,349,984 | 963,733 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $25,258,306 | 1,692,916 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $28,689,873 | 1,499,732 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $29,027,485 | 1,402,294 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $27,911,438 | 1,484,651 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $26,320,926 | 1,825,307 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $30,012,089 | 1,728,807 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $40,091,588 | 1,926,554 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $42,848,783 | 1,821,802 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $40,751,238 | 1,459,049 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $36,044,377 | 1,540,358 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $41,117,658 | 1,218,301 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $52,581,072 | 1,505,327 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $60,136,862 | 1,974,938 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $88,967,041 | 2,713,237 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $78,370,676 | 2,589,910 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||